10-K/A

BIOTIME, INC. 10-KA 12-31-2015

Company: Lineage Cell Therapeutics, Inc.
Filed: May 24, 2016
Period of Report: December 31, 2015
Accession Number: 0001140361-16-066868

View Document ↗ View on SEC.gov ↗